Loading...
Gubra Community
CPSE:GUBRA Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
Community Investing Ideas
Specialized CRO Models Will Expand Drug Discovery Amid Uncertainty
Key Takeaways Expansion of proprietary peptide pipeline and major partnerships diversify revenue streams and enhance earnings resilience beyond core CRO services. Investments in advanced preclinical platforms and global reach position Gubra to capture a larger, higher-margin market as outsourcing in biotech grows.Read more
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
DKK 502.5
9.3% undervalued intrinsic discount
AnalystConsensusTarget Fair Value
Revenue growth
-54% p.a.
Profit Margin
73.41%
Future PE
49.78x
Share price in 2028
DKK 569.94